London, United Kingdom [21st of February 2023] – Sanius Health and Modality Partnership are set to explore how AI-driven technologies can improve outcomes for severe asthma patients and tackle national A&E activity. Both organisations have curated an innovative programme that leverages insights derived from wearable technologies, giving providers and those seeking care a deeper visibility of lived patient experiences.
Asthma is a common and chronic respiratory condition that affects millions of people worldwide. Proper management of the condition is crucial for maintaining a good quality of life and reducing the risk of complications. The partnership between Sanius Health and Modality Partnerships is an important development as it brings together expertise from both the private and public sectors to improve care for asthma patients.
By leveraging Modality Partnership's extensive network of primary care providers and Sanius Health's expertise in digital health and patient ecosystems, this partnership aims to develop new tools and approaches for managing asthma to improve patient outcomes and reduce the burden on the NHS. This could include personalised digital care plans, remote monitoring, and AI-driven technologies for predicting and preventing asthma attacks.
According to Orlando Agrippa, CEO and Founder of Sanius Health, “the project’s use of our patient ecosystem and advanced digital health solutions has the potential to revolutionise the way we manage asthma”:
“By allowing patients to track their vitals, outcomes, and symptoms in real-time, they will be given more knowledge about adverse respiratory triggers. Identifying factors in their everyday life, especially those associated with asthma attacks, will allow patients in our programme to seek care before they have poor outcomes.”
“With these personalised insights, patients and their clinicians can create ways to manage their care better, prevent life-threatening health events and potentially, avoid visits to emergency departments.”
The use of Sanius’s Health ecosystem could also help identify patients at risk of severe asthma attacks, allowing healthcare providers to intervene earlier and prevent exacerbations. This could have significant implications for reducing the burden on the NHS, which currently sees high levels of A&E activity related to asthma.
Orlando adds, "Our goal is to provide patients with the tools they need to manage their condition effectively while supporting the NHS in managing capacity. By using our patient ecosystem to monitor asthma symptoms, we can ensure that patients receive timely and appropriate care, which can help to prevent hospital admissions and improve quality of life.”
The collaboration between Sanius Health and Modality Partnership is a positive development for asthma patients in the UK. It demonstrates a commitment to improving the management and care of this chronic condition. By working together, these organisations can leverage their strengths to develop innovative solutions that benefit patients and the NHS.
The programme is set to begin in the Spring of 2023 and will involve a cohort of 500 participants from across the UK. Patients who are interested in participating are encouraged to contact Sanius Health for more information.
